new glp 1 drug Decoding GLP-1 Weight Loss Medications With FDA approval of Wegovy

Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction

One noteworthy obstacle is the potential need for higher chemotherapy doses in obese patients based on their body weight

Pro-Survival and Energy Utilization GLP-1 activates pro-survival kinases within cardiac cells

doi: 10.3390/ijms24043506

There are emerging/established benefits for cardiovascular disease, heart failure, chronic kidney disease, sleep apnoea, osteoarthritis, and metabolic-associated steatotic liver disease [8]

Occasionally, authors may express opinions that represent their own viewpoint